Neuralink, Elon Musk's brain-chip company, is developing a new device requiring half the number of electrodes for implantation to enhance efficiency and power.

The announcement was made during a live stream on social media platform X.

In response to issues faced by the first participant in the device's trial, Neuralink is implementing risk mitigation measures, including skull sculpting and normalizing carbon dioxide levels in patients' blood.

The initial trial encountered problems with the tiny wires in the implant, prompting these safety enhancements.